Abiopharma

🔍 Hanson Jason David (Director)

Company: BullFrog AI Holdings, Inc. (BFRG)

Report Date: 2025-08-22

Detailed Transactions and Holdings:

• Acquired 5,710 shares of Common Stock (Direct)
  Date: 2025-08-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,710.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,813 shares of Common Stock (Direct)
  Date: 2025-08-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,523.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents Restricted Stock Units ("RSUs") issued under the Company's 2022 Equity Compensation Plan (the "Plan"), vesting 50% on September 1, 2026, and the remaining 50% on September 1, 2027. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing which may, or may not, constitute a change in control. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
• F2: Represents 2,813 shares of Common Stock issued as an equity grant under the Plan, fully vested upon grant.